Cargando…

A comparative study of propofol alone and propofol combined with midazolam for dental treatments in special needs patients

Although dental treatment with sedation is performed increasingly in special needs patients, data on adding midazolam to intravenous propofol sedation are very limited for this group. The purpose of this study was to identify the factors and procedure time associated with the use of intravenous seda...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, I-Hsin, Huang, Mao-Suan, Wang, Pei-Yu, Huang, Ta-Sen, Chong, See-Yen, Chen, Sam Li-Sheng, Tsai, Hung-Huey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183838/
https://www.ncbi.nlm.nih.gov/pubmed/34087890
http://dx.doi.org/10.1097/MD.0000000000026199
_version_ 1783704455706836992
author Lin, I-Hsin
Huang, Mao-Suan
Wang, Pei-Yu
Huang, Ta-Sen
Chong, See-Yen
Chen, Sam Li-Sheng
Tsai, Hung-Huey
author_facet Lin, I-Hsin
Huang, Mao-Suan
Wang, Pei-Yu
Huang, Ta-Sen
Chong, See-Yen
Chen, Sam Li-Sheng
Tsai, Hung-Huey
author_sort Lin, I-Hsin
collection PubMed
description Although dental treatment with sedation is performed increasingly in special needs patients, data on adding midazolam to intravenous propofol sedation are very limited for this group. The purpose of this study was to identify the factors and procedure time associated with the use of intravenous sedation with propofol alone or propofol combined with midazolam in dental patients with special needs. This was a retrospective data analysis. The sedation medications and relevant covariates, including demographic parameters, disability levels, oral health conditions, dental procedures, treatment time, and side effects, of 718 patients with special needs were collected between April 2013 and September 2014. The unfavorable side effects by sedation types were reported. Factors associated with procedure time and the sedation medications were assessed with multiple logistic regression analyses. Of 718 patients, 8 patients experienced unfavorable side effects (vomiting, sleepiness, or emotional disturbance) after the dental procedures; the rate was 0.6% in the 509 patients who received propofol only. In 209 patients who received propofol and midazolam, 2.4% experienced the side effects. Sedation time was associated with body mass index (BMI) < 25 (adjusted odds ratio [aOR] = 1.45, 95% confidence interval [CI]: 1.04–2.04) and the performance of multiple dental procedures (aOR = 1.44, 95% CI: 1.06–1.97) but not associated with the sedation types. A significant odds ratio for the combined use of propofol and midazolam was shown for adolescents (aOR = 2.22, 95% CI: 1.28–3.86), men (aOR = 2.05, 95% CI: 1.41–2.98), patients with cognitive impairment (aOR = 1.99, 95% CI: 1.21–3.29), and patients undergoing scaling procedures (aOR = 1.64, 95% CI: 1.13–2.39). With the acceptable side effects of the use of propofol alone and propofol combined with midazolam, multiple dental procedures increase the sedation time and the factors associated with the combined use of propofol and midazolam are younger age, male sex, recognition problems, and the type dental procedure in the dental treatment of patients with special needs.
format Online
Article
Text
id pubmed-8183838
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-81838382021-06-07 A comparative study of propofol alone and propofol combined with midazolam for dental treatments in special needs patients Lin, I-Hsin Huang, Mao-Suan Wang, Pei-Yu Huang, Ta-Sen Chong, See-Yen Chen, Sam Li-Sheng Tsai, Hung-Huey Medicine (Baltimore) 3300 Although dental treatment with sedation is performed increasingly in special needs patients, data on adding midazolam to intravenous propofol sedation are very limited for this group. The purpose of this study was to identify the factors and procedure time associated with the use of intravenous sedation with propofol alone or propofol combined with midazolam in dental patients with special needs. This was a retrospective data analysis. The sedation medications and relevant covariates, including demographic parameters, disability levels, oral health conditions, dental procedures, treatment time, and side effects, of 718 patients with special needs were collected between April 2013 and September 2014. The unfavorable side effects by sedation types were reported. Factors associated with procedure time and the sedation medications were assessed with multiple logistic regression analyses. Of 718 patients, 8 patients experienced unfavorable side effects (vomiting, sleepiness, or emotional disturbance) after the dental procedures; the rate was 0.6% in the 509 patients who received propofol only. In 209 patients who received propofol and midazolam, 2.4% experienced the side effects. Sedation time was associated with body mass index (BMI) < 25 (adjusted odds ratio [aOR] = 1.45, 95% confidence interval [CI]: 1.04–2.04) and the performance of multiple dental procedures (aOR = 1.44, 95% CI: 1.06–1.97) but not associated with the sedation types. A significant odds ratio for the combined use of propofol and midazolam was shown for adolescents (aOR = 2.22, 95% CI: 1.28–3.86), men (aOR = 2.05, 95% CI: 1.41–2.98), patients with cognitive impairment (aOR = 1.99, 95% CI: 1.21–3.29), and patients undergoing scaling procedures (aOR = 1.64, 95% CI: 1.13–2.39). With the acceptable side effects of the use of propofol alone and propofol combined with midazolam, multiple dental procedures increase the sedation time and the factors associated with the combined use of propofol and midazolam are younger age, male sex, recognition problems, and the type dental procedure in the dental treatment of patients with special needs. Lippincott Williams & Wilkins 2021-06-04 /pmc/articles/PMC8183838/ /pubmed/34087890 http://dx.doi.org/10.1097/MD.0000000000026199 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/)
spellingShingle 3300
Lin, I-Hsin
Huang, Mao-Suan
Wang, Pei-Yu
Huang, Ta-Sen
Chong, See-Yen
Chen, Sam Li-Sheng
Tsai, Hung-Huey
A comparative study of propofol alone and propofol combined with midazolam for dental treatments in special needs patients
title A comparative study of propofol alone and propofol combined with midazolam for dental treatments in special needs patients
title_full A comparative study of propofol alone and propofol combined with midazolam for dental treatments in special needs patients
title_fullStr A comparative study of propofol alone and propofol combined with midazolam for dental treatments in special needs patients
title_full_unstemmed A comparative study of propofol alone and propofol combined with midazolam for dental treatments in special needs patients
title_short A comparative study of propofol alone and propofol combined with midazolam for dental treatments in special needs patients
title_sort comparative study of propofol alone and propofol combined with midazolam for dental treatments in special needs patients
topic 3300
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183838/
https://www.ncbi.nlm.nih.gov/pubmed/34087890
http://dx.doi.org/10.1097/MD.0000000000026199
work_keys_str_mv AT linihsin acomparativestudyofpropofolaloneandpropofolcombinedwithmidazolamfordentaltreatmentsinspecialneedspatients
AT huangmaosuan acomparativestudyofpropofolaloneandpropofolcombinedwithmidazolamfordentaltreatmentsinspecialneedspatients
AT wangpeiyu acomparativestudyofpropofolaloneandpropofolcombinedwithmidazolamfordentaltreatmentsinspecialneedspatients
AT huangtasen acomparativestudyofpropofolaloneandpropofolcombinedwithmidazolamfordentaltreatmentsinspecialneedspatients
AT chongseeyen acomparativestudyofpropofolaloneandpropofolcombinedwithmidazolamfordentaltreatmentsinspecialneedspatients
AT chensamlisheng acomparativestudyofpropofolaloneandpropofolcombinedwithmidazolamfordentaltreatmentsinspecialneedspatients
AT tsaihunghuey acomparativestudyofpropofolaloneandpropofolcombinedwithmidazolamfordentaltreatmentsinspecialneedspatients
AT linihsin comparativestudyofpropofolaloneandpropofolcombinedwithmidazolamfordentaltreatmentsinspecialneedspatients
AT huangmaosuan comparativestudyofpropofolaloneandpropofolcombinedwithmidazolamfordentaltreatmentsinspecialneedspatients
AT wangpeiyu comparativestudyofpropofolaloneandpropofolcombinedwithmidazolamfordentaltreatmentsinspecialneedspatients
AT huangtasen comparativestudyofpropofolaloneandpropofolcombinedwithmidazolamfordentaltreatmentsinspecialneedspatients
AT chongseeyen comparativestudyofpropofolaloneandpropofolcombinedwithmidazolamfordentaltreatmentsinspecialneedspatients
AT chensamlisheng comparativestudyofpropofolaloneandpropofolcombinedwithmidazolamfordentaltreatmentsinspecialneedspatients
AT tsaihunghuey comparativestudyofpropofolaloneandpropofolcombinedwithmidazolamfordentaltreatmentsinspecialneedspatients